In medical news, a cheap and widely prescribed antidepressant pill known as fluvoxamine showed promise in blunting the effects of COVID-19 in patients in Brazil. A clinical trial showed that when taken soon after infection, the drug cut the length of patients’ hospital stays and reduced their risk of death.